Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM).

Clinical trial NCT07020377 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT07020377
Sponsor: Amira Bisher,PhD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Diabetes Mellitus Non Alcholic Fatty Liver Disease

Start date: 2024-01-15
Primary completion: 2025-12-20
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.